22nd Century Group’s (XXII) “Sell (E+)” Rating Reaffirmed at Weiss Ratings

Weiss Ratings restated their sell (e+) rating on shares of 22nd Century Group (NASDAQ:XXII) in a research note issued to investors on Saturday morning,Weiss Ratings reports.

Separately, StockNews.com cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Stock Down 17.6 %

Shares of NASDAQ:XXII opened at $5.10 on Friday. 22nd Century Group has a 1 year low of $3.90 and a 1 year high of $581.85. The company has a market capitalization of $2.81 million, a PE ratio of 0.00 and a beta of 1.59. The business has a fifty day moving average price of $8.88 and a two-hundred day moving average price of $38.08. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93.

22nd Century Group (NASDAQ:XXII) last posted its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The company had revenue of $5.95 million for the quarter.

Institutional Investors Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP bought a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent reporting period. Institutional investors and hedge funds own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.